Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study

2016393 citationsJournal Articlehybrid Open Access

Authors

NCT01721057; Results.

Good health and well-being

Published in: Annals of the Rheumatic Diseases

Volume 76, Issue 1, pp. 88-95

Field-Weighted Citation Impact: 35.62